tradingkey.logo
tradingkey.logo
Search

Briacell Therapeutics Corp

BCTX
Add to Watchlist
4.010USD
-0.080-1.96%
Close 09-23 16:00ET
34.89MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-1.96%

5 Days

+12.64%

1 Month

-1.47%

6 Months

-5.65%

Year to Date

-43.60%

1 Year

-57.34%

Key Figures

4.010Open
4.180High
3.23KVolume
LossP/E TTM
0.00P/E Dynamic
--Dividend TTM
0.04%Turnover Ratio
4.090Prev. Close
3.978Low
13.09KTurnover
LossP/E Static
1.46P/B
0.00%Div Yield TTM
-139.50%ROA
14.68052wk High
0.01Volume Ratio
-26.31MNet Profit
8.70MShares
-14.4132EPS TTM
1.65Beta
-171.72%ROE
2.60052wk Low
10.88%Amplitude
--Gross Margin
34.89MMarket Cap
-1.06Reward/Risk
7.22%Risk Rate
More news coming soon, stay tuned...

Briacell Therapeutics Corp's Score

-0.02vs previous score
Forecast--
Financial Health7.21
Technical4.62
Valuation Dimensions7.96
Institutional Confidence3.00
Risk Assessment--

Media Coverage

Coverage Level

Very Low
Very High
Positive

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
40.000Target Price
+199.85%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy00000000
Buy00001111
Hold00000000
Sell00000000
Strong Sell00000000

Briacell Therapeutics Corp Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Neutral

Summary

Neutral

Moving Average

Buy

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.99/-2.74
Revenue / Forecast
--/0.00

Briacell Therapeutics Corp Profile

SectorBiotechnology & Medical Research
Ticker SymbolBCTX
Number of employees22
CountryCanada

Ownership

ShareholdersProportion
Iridian Asset Management LLC0.90%
Iroquois Capital Management, LLC0.79%
L5 Capital Inc.0.24%
UBS Financial Services, Inc.0.16%
Shareholder TypesProportion
Investment Advisor/Hedge Fund1.13%
Hedge Fund0.79%
Corporation0.24%
Investment Advisor0.17%

FAQs

What is the current price of Briacell Therapeutics Corp (BCTX)?

The current price of Briacell Therapeutics Corp (BCTX) is 4.01.

What is the symbol of Briacell Therapeutics Corp?

The ticker symbol of Briacell Therapeutics Corp is BCTX.

What is the 52-week high of Briacell Therapeutics Corp?

The 52-week high of Briacell Therapeutics Corp is 14.68.

What is the 52-week low of Briacell Therapeutics Corp?

The 52-week low of Briacell Therapeutics Corp is 2.60.

What is the market capitalization of Briacell Therapeutics Corp?

The market capitalization of Briacell Therapeutics Corp is 34.89M.

Is Briacell Therapeutics Corp (BCTX) currently rated as Buy, Hold, or Sell?

According to analysts, Briacell Therapeutics Corp (BCTX) has an overall rating of Buy, with a price target of 40.00.

What is the Earnings Per Share (EPS TTM) of Briacell Therapeutics Corp (BCTX)?

The Earnings Per Share (EPS TTM) of Briacell Therapeutics Corp (BCTX) is -14.41.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.